FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053826377> ?p ?o ?g. }

• W2053826377 endingPage "380" @default.
• W2053826377 startingPage "375" @default.
• W2053826377 abstract "Free AccessPositive Airway PressurePFO and Right-to-Left Shunting in Patients with Obstructive Sleep Apnea Marina Guchlerner, M.D, Peter Kardos, M.D, Eva Liss-Koch, M.D, Jennifer Franke, M.D, Nina Wunderlich, M.D, Stefan Bertog, M.D, Horst Sievert, M.D Marina Guchlerner, M.D CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany Search for more papers by this author , Peter Kardos, M.D Gemeinschaftspraxis und Zentrum für Pneumologie, Allergologie & Schlafmedizin, Klinik Maingau, Frankfurt, Germany Search for more papers by this author , Eva Liss-Koch, M.D Gemeinschaftspraxis und Zentrum für Pneumologie, Allergologie & Schlafmedizin, Klinik Maingau, Frankfurt, Germany Search for more papers by this author , Jennifer Franke, M.D CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany Search for more papers by this author , Nina Wunderlich, M.D CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany Search for more papers by this author , Stefan Bertog, M.D CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany Search for more papers by this author , Horst Sievert, M.D Address correspondence to: Prof. Dr. Horst Sievert, CardioVascular Center Frankfurt, Seckbacher Landstrasse 65, 60389 Frankfurt, Germany+49-69-4603-1344+49-69-4603-1343 E-mail Address: [email protected] CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany Search for more papers by this author Published Online:August 15, 2012https://doi.org/10.5664/jcsm.2026Cited by:18SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTBackground:Patent foramen ovale (PFO) with right-to-left shunt has a prevalence of 10% to 34% in the general population. It can cause an ischemic stroke, transient ischemic attack, and paradoxical peripheral or coronary embolization. Its influence on migraine and several other diseases and conditions is currently under debate. Attention has recently been turned to the correlation between PFO and obstructive sleep apnea. Thus far, studies on the prevalence of right-to-left shunts as a surrogate for PFO in these patients were limited by small sample sizes and the results have been conflicting. Here, we evaluate the prevalence of right-to-left shunting (RLS) through transcranial Doppler ultrasound (TCD) in a large patient group with obstructive sleep apnea (OSA).Methods:One hundred consecutive patients (mean age 59.5 y) with OSA underwent TCD with intravenous injection of agitated saline. The grading of right-to-left-shunts was in accordance with the Spencer PFO Grading Scale.Results:RLS was detected in 72 of 100 patients (72%). Thirty-four out of these 72 patients (47%) had a shunt grade I or II; 15 (21%) had a shunt Grade III or IV; and 23 (32%) had a large shunt (Grade V or V+). In 47 of 72 patients (65%), a right-to-left shunt was detectable at rest without Valsalva maneuver.Conclusion:The prevalence of a RLS in patients with OSA is high. Provided other intracardiac or pulmonary shunts were absent, the high prevalence of a RLS suggests a high prevalence of PFO in patients with OSA.Citation:Guchlerner M; Kardos P; Liss-Koch E; Franke J; Wunderlich N; Bertog S; Sievert H. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med 2012;8(4):375–380.INTRODUCTIONApatent foramen ovale (PFO) can be detected in autopsy studies in 15% to 34% in the general population.1–3 It is reported in 26% of a randomly selected population cohort examined by transesophageal echocardiography (TEE).4 A higher prevalence has been reported in patients suffering from migraine or cluster headache,5,6 as well as in subjects with ischemic stroke.7 Case reports of thrombi-in-transit and a plausible physiologic mechanism support the notion that PFO are a potential cause for paradoxical peripheral and coronary embolization8 and decompression sickness.9Transesophageal echocardiography using contrast (agitated saline injection) has been demonstrated to have a high sensitivity and specificity for the detection of a PFO causing a right-to-left shunt when compared with autopsy studies3 and has, therefore, been considered the gold standard diagnostic test for the detection of a PFO. However, recent studies have shown contrast-enhanced TCD and TEE to be complementary techniques in the assessment of a PFO.10In fact, some evidence suggests that TCD may be more sensitive in the detection of RLS than echocardiographic imaging.11 Therefore, this technique may be able to exclude PFO causing RLS with a higher level of confidence than TEE and transthoracic echocardiography.12 Assuming no other (unusual) intracardiac or intrapulmonary shunts are present, a RLS detected on TCD is indicative of a PFO. Furthermore, TCD is considerably less invasive for the patient, and the Valsalva maneuver, which significantly increases microbubble appearance,13 can be performed more accurately. Further investigations demonstrated that the unilateral detection of RLS by power M-mode transcranial Doppler, used in this study, provided an equivalent sensitivity to a bilateral detection,14 while easier to handle. Recognizing the limitation that, in unusual circumstances, a RLS detected on TCD may be the source of other intracardiac or intrapulmonary shunts and that a PFO may remain silent if it causes left-to-right shunting only, the presence of RLS demonstrated by TCD will, for the remainder of this discussion and manuscript, be assumed to be the consequence of PFO with RLS. Moreover, the term “PFO” will indicate PFO with RLS unless otherwise stated.Brief SummaryCurrent Knowledge/Study Rationale: Right-to-left shunting (RLS) via a patent foramen ovale (PFO) may exacerbate hypoxemia caused by apneic episodes. In addition, apneic episodes may promote right-to-left shunting through a foramen ovale. To date, it has not yet been determined whether obstructive sleep apnea (OSA) is associated with a higher prevalence of RLS through a patent foramen ovale.Study Impact: Our findings may impact the management of patients with OSA. It should stimulate further investigations to determine if patients with severe OSA and RLS through a PFO should undergo PFO closure.Obstructive sleep apnea (OSA) is a common condition affecting 17% to 26% of men and 9% to 28% of women over 30 years of age with a higher prevalence in both the elderly and the overweight.15–17 Several disorders are associated with this condition: systemic and pulmonary hypertension, ischemic heart disease, cardiac arrhythmia, cerebrovascular disease, congestive heart failure,18–20 as well as cognitive dysfunction21 and an increased risk of accidents as a result of daytime sleepiness.22Improvements in the degree of hypoxemia in patients with both OSA and PFO after closure of the PFO are conceivable. Data, to support this, however are limited to case reports. For example, subjective improvement in sleep apnea symptoms and objective improvement in polysomnographic testing after transcutaneous closure of a PFO in a patient after ischemic stroke have been reported.23 Moreover, complete resolution of symptoms in a patient with OSA and desaturations during exercise has been described.24It is not yet clear whether OSA, by virtue of increased mean transmural pulmonary artery pressure during apneic episodes,25 may allow an interatrial communication (PFO) that otherwise would be unrecognized, whether the PFO is a substantial contributor in the pathogenesis of OSA, or whether both apply.Recent research indicates that carbon dioxide retention and hypoxemia during nocturnal apneic episodes in patients with obstructive sleep apnea (OSA) lead to an elevation of pulmonary vascular resistance followed by an increase in right ventricular afterload and right atrial pressure. Under these conditions, right-to-left shunting via PFO may exacerbate the hypoxemia caused by apneic episodes.26Importantly, it has not yet been determined whether OSA is associated with an increased prevalence of PFO. Previous studies examining the prevalence of PFO in patients with OSA have produced conflicting results.27,28The aim of this study was to evaluate the prevalence of right-to-left shunting by means of TCD in a large group of patients with obstructive sleep apnea syndrome. Care was taken to include a nonselected cohort of consecutive patients representative of a general OSA population.PATIENTS AND METHODSStudy SampleOne hundred consecutive patients first time diagnosed with OSA after clinical assessment and inpatient overnight sleep studies requiring nocturnal positive airway pressure treatment were screened for PFO.PolysomnographyThe diagnosis of OSA was made after performing a standard nocturnal polysomnography including electroencephalogram, electroculograms, single-lead electrocardiogram, anterior tibial and submental electromyograms, finger pulse oximetry, and measurements of oro-nasal-airflow as well as abdominal and chest excursions.A single expert evaluated the polysomnograms manually. Respiratory events were counted as apnea if a cessation of airflow ≥ 10 sec occurred. Hypopnea was defined as ≥ 50% reduction of airflow, in association with an oxygen desaturation ≥ 4% from the baseline value, lasting > 10 seconds.Continuous oxygen saturation (SaO2) measurement allowed determination of the number of desaturations > 4% per hour sleep time (oxygen desaturation index, ODI). The frequency of apneas and hypopneas per hour of sleep (apnea hypopnea index, AHI) defined the OSA severity. AHI > 5 was considered pathological.Shunt Detection and AssessmentTo evaluate the presence of PFO, a transcranial Doppler was performed in every patient. We used the ST3 Digital Transcranial Doppler System Model PMD 150 (Spencer Technologies, Seattle, WA, USA), with Power M-Mode and injection of contrast medium, to discover RLS. The machine provides 33 gates of continuous Doppler information across a 66 mm depth range. There are 2 sections on display: Digital Power M-Mode (mm): This shows all blood flow within a depth range. Blue represents blood flow away from the transducer, red towards the transducer. Brighter color corresponds to stronger signals. Blood flow signals cause a horizontal streak across the screen when located.Spectrogram (cm/s): shows a Doppler spectral waveform that indicates the velocity profile of blood flow in the selected depth.All examination data were stored internally and analyzed offline afterwards by a single experienced researcher.Patients were placed in supine position with their head slightly elevated. An intravenous catheter (20-gauge) was inserted into the antecubital vein. The transcranial 2 MHz ultrasound probe was fixed unilaterally on the patients' head, at the height of the temporal bone window, by using the Marc 600 Headframe System (Spencer Technologies, Seattle, WA). The Doppler signal of blood flow in the middle cerebral artery was located at a depth of 45-65 mm. At this point, the Valsalva maneuver was exercised with the patient: the patient was asked to take a deep breath and press against the closed epiglottis for 10 sec to increase the thoracic pressure. The maneuver was considered successful if a 30% reduction of mean flow velocity in the middle cerebral artery could be observed for the entire 10-sec period. Before recording, two 10-mL syringes were connected to the intravenous catheter by means of a 3-way stopcock: one containing 9 mL of 3.5% colloidal solution Haemaccel (TheraSelect, Marburg, Germany) and 1 mL of air, the other empty. The content was agitated by rapidly pushing it from one syringe to the other, resulting in a homogenous solution (the contrast agent).In the following examination, 2 sessions were performed: in the first session the contrast bolus was rapidly injected (within 6-8 sec) with the patient at rest during physiological respiration. In the second session, the patient was asked to perform the Valsalva maneuver as previously practiced. Midway through the injection, the patient was instructed to start the Valsalva maneuver and hold it for 10 sec before breathing normally again. There was a 5-min break between the sessions to allow the recirculating bubbles to disperse. Embolic tracks were counted for a total of 60 sec after the end of each injection.Microembolic signals can be distinguished from artifacts (caused by patient movement, swallowing, chewing, or manipulation of the probe) in the spectrogram by their characteristic sound and look. It is a short click-sound (< 300 ms) of high intensity, visible as a white streak within the Doppler flow spectrum (Figure 1A and B).Figure 1A: ST3 Digital Transcranial Doppler System Model PMD 150; divided display: power M-Mode (upper part), spectrogram (lower part); One microembolic signal (MES)Download Figure1B: Curtain pattern: uncountable MES; Shunt grade V+Download FigureThe magnitude of right-to-left shunting was classified according to the Spencer grading Scale (Spencer Vascular Laboratories, Seattle, Washington, USA; Table 1)29 A right-to-left shunt was noted to be present if ≥ 1 clear microembolic signal had been recorded within 60 sec after the end of the injection. At-rest shunting was noted if the patient showed a shunt during the first session (at physiological respiration). Provocative-only shunting was defined as microembolic signals (MES) recorded only during Valsalva maneuver and not under resting conditions.Table 1 Spencer Grading Scale; MES: microembolic signalsTable 1 Spencer Grading Scale; MES: microembolic signalsStatistical AnalysisStatistical calculations were performed using the software “BiAS for Windows” version 9.07 (epsilon-Verlag, Darmstadt, Germany). Descriptive statistics were performed for demographic and polysomnographic characteristics (Table 2).Table 2 Studied clinical parameters (mean ± SD)Table 2 Studied clinical parameters (mean ± SD)We evaluated the prevalence of PFO as well as the magnitudes of the right-to-left shunt in the study sample. The distribution of provocative-only shunting was compared to at-rest shunting.The Mann-Whitney-Wilcoxon Test was used to compare continuous variables in the groups “no shunt” to “shunt” and, within the “shunt” group, to compare “at-rest shunting” to “provocative-only shunting.” The clinical parameters considered were age, height, weight, body mass index, AHI, ODI, AHI/ODI, baseline SaO2 during sleep, and lowest SaO2 during sleep.The Fisher exact test was used to compare categorical variables in the groups “no shunt” and “shunt.” Gender and preexisting illnesses (hypertension, diabetes, coronary artery disease, atrial fibrillation, COPD/asthma, stroke; Table 3) were included in the analysis (Table 4). Spearman rank correlation was calculated to test for a statistically significant association between shunt magnitude and clinical parameters. A p value < 0.05 was considered statistically significant.Table 3 Concomitant diseases in study populationTable 3 Concomitant diseases in study populationTable 4 Relation between concomitant diseases and right-to-left shunt/shunt magnitudeTable 4 Relation between concomitant diseases and right-to-left shunt/shunt magnitudeRESULTSThere were 19 females and 81 males in the study population. The mean age was 59.5 ± 11.7 years, mean BMI 33.2 ± 6.4 kg/m2 and mean AHI 44.2 ± 22.2/h (Table 2).In 72 of 100 (72%) patients, a right-to-left shunt was detected. Forty-seven of 72 patients (65%) showed “at-rest shunting”—a right-to-left shunt during physiological respiration. A “provocative-only shunt”—a right-to-left shunt only after Valsalva maneuver—was present in 25 patients.Out of these 72 patients, 34 (47%) had a small shunt (< 15 MES, conforming to grade I or II in the Spencer grading Scale); 38 patients (53%) had a large shunt (grade III to V+); and in 18 patients a curtain pattern was seen in TCD (V+).There was no significant correlation with the following parameters: gender, BMI, AHI, ODI, AHI/ODI, nadir oxygen saturation, lowest oxygen saturation, or concomitant diseases, and the presence or absence of a shunt either at rest or with Valsalva. In addition, there was no significant correlation between the shunt magnitude and any of the aforementioned parameters.DISCUSSIONThe study reveals right-to-left shunting in 72% of patients with OSA. Provided no other sources (i.e., an intrapulmonary or other intracardiac RLS) are present, the etiology of the RLS in these patients is PFO. This is approximately three times higher than the reported prevalence of PFO in the general population at autopsy. It is also significantly higher than the prevalence reported by TEE in a large randomly selected population cohort (26%).4 Of note, in the overwhelming majority in that cohort the PFO was diagnosed based on the presence of a RLS by contrast (agitated saline) injection. Our results confirm findings by Shoundy et al.27 The prevalence of PFO was 69% in patients with OSA analyzed by TEE (48 patients). In contrast, in a TCD-study (78 patients), Beelke et al. report a prevalence of only 27%, which lies within the range expected in the general population.28 However, this study only evaluated a selected group of patients with OSA. Patients with myocardial infarction, unstable angina, congestive heart failure, pulmonary embolism, transient ischemic attack, stroke, or migraine—all conditions frequently found in patients with OSA30—were excluded. Thus the study population may not have be representative of the general OSA patient population. Transcranial Doppler data regarding the prevalence of a RLS in a healthy population are limited and it could be argued that TCD is more sensitive or overestimates the true prevalence of RLS. However, though perhaps slightly more sensitive than TEE,10 the differences in reported prevalences between both modalities are small.It has been hypothesized, that the high prevalence of PFO with RLS in OSA patients could be due to enhanced respiratory effort during apneic episodes causing a rise in right atrial pressure, allowing reopening of a patent but formerly closed foramen26; however, increased right atrial pressures in patients with isolated OSA have not yet been demonstrated. Likewise, increased right-sided pressure related to pulmonary hypertension may facilitate interatrial communication via the foramen ovale. Though it is controversial whether OSA alone (in the absence of concomitant pulmonary disease or daytime hypoxemia) can cause pulmonary hypertension, some recent data in patients whose sleep apnea was treated with continuous positive airway pressure causing a significant reduction in pulmonary artery pressure in the absence of changes in daytime hypoxemia or lung function tests does support the notion that OSA can lead to an increase (albeit mild) in pulmonary artery pressure.31 Finally, both mechanisms in concert may permit a patent foramen ovale to re-establish. To this effect, high pulmonary artery systolic pressure is often measured in patients with OSA32 and attributed to pulmonary vasoconstriction caused by hypoxemia.33 Though the prevalence of PFO in patients with pulmonary hypertension is reported to be similar to the general population,34 a study of patients with chronic obstructive pulmonary disease (COPD) shows a significantly higher pulmonary artery systolic pressure and an increased prevalence for PFO assessed by transesophageal (agitated saline-) contrast echocardiography (70%).35 Moreover, these patients experience significant systemic arterial oxygen desaturation after the Valsalva maneuver.Similar observations have been made in OSA patients with PFO: these patients experience more oxygen desaturations in proportion to respiratory events (episodes of hypopnea and apnea) than patients without PFO. There appears to be a higher prevalence of PFO in patients with deep desaturations than in those with milder degrees (60% vs. 13%).36 The right-to-left shunt occurring during obstructive respiratory disturbances (i.e., patients pressing against closed upper airway) allows deoxygenated venous blood to enter the arterial system and thereby may decrease arterial oxygen saturation.There is a high correlation between MES count in TCD and PFO size.37 Thus one may assume that a larger shunt in TCD is related to a larger defect. The role of PFO and shunt size in the severity of desaturation is still not fully understood. In the current study, a significant correlation between shunt size and AHI (which indicates severity of OSA) could not be found.There was no significant associated between any of the evaluated clinical parameters to the presence a shunt or its magnitude. This corresponds with previous study results.27,28Case reports suggest an association between OSA and PFO. For example, in support of the hypothesis that PFO may exacerbate hypoxemia and unfavorably affect physiologic sleep parameters, significant improvements of OSA symptoms were reported after PFO closure.23,24 Furthermore, favoring the notion that OSA may allow reestablishment of an interatrial communication, treatment of OSA with continuous positive airway pressure (CPAP) has been reported to suppress a previously existing shunt occurring through a PFO.38 It is conceivable that the higher prevalence of right-to-left shunting via a patent foramen ovale in patients with OSA may be responsible for a higher stroke incidence in patients with OSA.39 Hence, the importance of an association between PFO and OSA is not to be underestimated. Given the substantial and rising number of patients with OSA, the investigation of the following aspects should be among the priorities in studying this patient population: First, it would be very important to prospectively establish whether individuals with OSA and PFO are more likely to experience strokes and, perhaps, are more likely to suffer from pulmonary or systemic hypertension than those with OSA and absent interatrial communication. Second, given the demonstrated procedural safety,40 the impact of percutaneous PFO closure on the incidence of strokes and other undesired associated conditions such as pulmonary hypertension and systemic hypertension in this patient population should be investigated. Though it would allow further elucidation of the physiology and association of OSA and PFO, a randomized comparison of patients with OSA and PFO treated with CPAP compared to no treatment is, of course, unethical.LimitationsAs described in the introduction, TCD cannot distinguish between a shunt occurring through a PFO and a shunt on a pulmonary level.41 Albeit the latter is rare,42 its role in the pathophysiology of OSA is unknown. Likewise, a PFO causing exclusively left-to-right shunting may remain silent on TCD imaging. The clinical significance of this possibility is unclear. In addition, optimally, the prevalence of RLS in patients with OSA should be compared to that of a general population using the same imaging modality to minimize errors related to the imaging procedure itself.CONCLUSIONThe prevalence of a RLS assessed by TCD is high in patients with OSA. Provided no unrecognized other unusual intracardiac or intrapulmonary shunts are present in OSA patients, this is likely related to a high prevalence of PFO in this population. To confirm our findings, further studies comparing the prevalence of a RLS in OSA patients to that of a healthy population are warranted. It remains to be investigated whether PFO are risk factors for OSA or, to the contrary, if OSA helps maintain a PFO or leads to re-opening of a formerly closed foramen ovale. Lastly, further research is needed to determine whether PFO exacerbate the symptoms of sleep apnea or may be associated with a higher incidence of strokes in patients with OSA and, therefore, if a PFO closure should be considered in these patients.DISCLOSURE STATEMENTThis was not an industry supported study. Prof. Sievert reports having study honorary, travel expenses and consulting fees from Access Closure, AGA, Angiomed, Ardian, Arstasis, Atritech, Atrium, Avinger, Bard, Boston Scientific, Bridgepoint, CardioK inetix, CardioMEMS, Coherex, Contego, CSI, EndoCross, EndoTex, Epitek, Evalve, ev3, FlowCardia, Gore, Guidant, Lumen Biomedical, HLT, Kensey Nash, Kyoto Medical, Lifetech, Lutonix, Medinol, Medtronic, NDC, NMT, OAS, Occlutech, Osprey, Ovalis, Pathway, PendraCare, Percardia, PFM Medical, Recor, Rox Medical, Sadra, Sorin, Spectranetics, SquareOne, Trireme, Trivascular, Viacor, Velocimed, and Veryanand. He also holds stock options in Cardiokinetix, Access Closure, Velocimed, CoAptus, Lumen Biomedical, Coherex. The other authors have indicated no financial conflicts of interest.REFERENCES1 Hagen PTScholz DGEdwards WDIncidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal heartsMayo Clin Proc1984591720, 6694427CrossrefGoogle Scholar2 Penther PPatent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsiesArch Mal Coeur Vaiss1994871521, 7811147Google Scholar3 Schneider BZienkiewicz TJansen VHofmann TNoltenius HMeinertz TDiagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsie findingsAm J Cardiol19967712029, 8651096CrossrefGoogle Scholar4 Meissner IWhisnant JPKhandheria BK, et al.Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a CommunityMayo Clin Proc1999748629, 10488786CrossrefGoogle Scholar5 Della Volta GGuindani MZavarise PGriffini SPezzini APadovani APrevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotypeJ Headache Pain2005632830, 16362702CrossrefGoogle Scholar6 Morelli NGori SCafforio G, et al.Prevalence of right-to-left shunt in patients with cluster headacheJ Headache Pain200562446, 16362676CrossrefGoogle Scholar7 Lechat PMas JLLascault G, et al.Prevalence of patent foramen ovale in patients with strokeN Eng J Med1988318114852CrossrefGoogle Scholar8 Horton SCBunch TJPatent foramen ovale and strokeMayo Clin Proc2004797988, 14708951CrossrefGoogle Scholar9 Schwerzmann MSeiler CLipp E, et al.Relation between directly detected patent foramen ovale and ischemic brain lesions in sport diversAnn Intern Med2001134214, 11187416CrossrefGoogle Scholar10 Droste DWSchmidt-Rimpler CWichter T, et al.Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonographyCerebrovasc Dis2004171916, 14707421CrossrefGoogle Scholar11 Van HPoommipanit PShalaby MGevorgyan RTseng CHTobis JSensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shuntJACC Cardiovasc Imaging201033438, 20394894CrossrefGoogle Scholar12 Souteyrand GMotreff PLusson JR, et al.Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patientsEur J Echocardiography2006714754CrossrefGoogle Scholar13 Horner SNi XSWeihs W, et al.Simultaneous bilateral contrast transcranial doppler monitoring in patients with intracardiac and intrapulmonary shuntsJ Neurol Sci19971504957, 9260857CrossrefGoogle Scholar14 Jesurum JTFuller CJMoehring MARenz JHarley MSpencer MPUnilateral versus bilateral middle cerebral artery detection of right-to-left shunt by power M-mode transcranial DopplerJ Neuroimaging20091923541, 18826441CrossrefGoogle Scholar15 Young TPalta MDempsey JSkatrud JWeber SBadr SThe occurence of sleep-disordered breathing among middle-aged adultsN Engl J Med199332812305, 8464434CrossrefGoogle Scholar16 Bixler EVgontzas ATen Have TTyson KKales AEffects of age on sleep apnea in menAm J Respir Crit Care Med19981571448, 9445292CrossrefGoogle Scholar17 Bixler EOVgontzas ANLin HM, et al.Prevalence of sleep-disordered breathing in womenAm J Respir Crit Care Med200116360813, 11254512CrossrefGoogle Scholar18 Ferguson KAFleetham JASleep-related breathing disorders: consequences of sleep disordered breathingThorax1995509981004, 8539686CrossrefGoogle Scholar19 Dempsey JASleep apnea causes daytime hypertensionJ Clin Invest19979912, 9011562CrossrefGoogle Scholar20 Guidry UCMendes LAEvans JC, et al.Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart StudyAm J Respir Crit Care Med20011649338, 11587973CrossrefGoogle Scholar21 Pierobon AGiardini AFanfulla FCallegari SMajani GA multidimensional assessment of obese patients with obstructive sleep apnea syndrom (OSAS): A study of psychological, neuropsychological and clinical relationships in a disabling multifaceted diseaseSleep Med20088882926, 18226950CrossrefGoogle Scholar22 Gottlieb DJWhitney CWBonekat WH, et al.Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health StudyAm J Respir Crit Care Med19991595027, 9927364CrossrefGoogle Scholar23 Silver BGreenbaum AMcCarthy SImprovement in sleep apnea associated with closure of a patent foramen ovaleJ Clin Sleep Med200732956, 17561600LinkGoogle Scholar24 Agnoletti GIserin LLafont ASidi DDesnos MObstructive sleep apnoea and patent foramen ovale: successful treatment of symptoms by percoutaneous foramen ovale closureJ Interven Cardiol2005183935CrossrefGoogle Scholar25 Schaefer HHasper EEwig S, et al.Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factorsEur Respir J19981267984, 9762799CrossrefGoogle Scholar26 Beelke MAngeli SDel Sette M, et al.Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovaleSleep200225217CrossrefGoogle Scholar27 Shanoudy HSoliman ARaggi PLiu JWRussell DCJarmukli NFPrevalence of patent foramen ovale and its contribution to hypoxemia in patients wi" @default.
• W2053826377 created "2016-06-24" @default.
• W2053826377 creator A5007497294 @default.
• W2053826377 creator A5028353205 @default.
• W2053826377 creator A5035079173 @default.
• W2053826377 creator A5049607555 @default.
• W2053826377 creator A5055290227 @default.
• W2053826377 creator A5073440750 @default.
• W2053826377 creator A5078140879 @default.
• W2053826377 date "2012-08-15" @default.
• W2053826377 modified "2023-10-15" @default.
• W2053826377 title "PFO and Right-to-Left Shunting in Patients with Obstructive Sleep Apnea" @default.
• W2053826377 cites W1714259827 @default.
• W2053826377 cites W1962501432 @default.
• W2053826377 cites W1967855176 @default.
• W2053826377 cites W1969864986 @default.
• W2053826377 cites W1971020352 @default.
• W2053826377 cites W1972126367 @default.
• W2053826377 cites W1977193054 @default.
• W2053826377 cites W1990004393 @default.
• W2053826377 cites W1991070150 @default.
• W2053826377 cites W2002299413 @default.
• W2053826377 cites W2006531183 @default.
• W2053826377 cites W2008016959 @default.
• W2053826377 cites W2018905155 @default.
• W2053826377 cites W202088654 @default.
• W2053826377 cites W2027764851 @default.
• W2053826377 cites W2038862359 @default.
• W2053826377 cites W2049018971 @default.
• W2053826377 cites W2051273331 @default.
• W2053826377 cites W2051719948 @default.
• W2053826377 cites W2053389613 @default.
• W2053826377 cites W2068743036 @default.
• W2053826377 cites W2080602680 @default.
• W2053826377 cites W2098456654 @default.
• W2053826377 cites W2102612844 @default.
• W2053826377 cites W2103939721 @default.
• W2053826377 cites W2110158978 @default.
• W2053826377 cites W2119213758 @default.
• W2053826377 cites W2145054501 @default.
• W2053826377 cites W2146247062 @default.
• W2053826377 cites W2148345618 @default.
• W2053826377 cites W2151720801 @default.
• W2053826377 cites W2156844124 @default.
• W2053826377 cites W2159083599 @default.
• W2053826377 cites W2161959892 @default.
• W2053826377 cites W2164693599 @default.
• W2053826377 cites W2326526061 @default.
• W2053826377 cites W2333343699 @default.
• W2053826377 cites W3023775830 @default.
• W2053826377 cites W60653209 @default.
• W2053826377 cites W62431919 @default.
• W2053826377 cites W2017710930 @default.
• W2053826377 doi "https://doi.org/10.5664/jcsm.2026" @default.
• W2053826377 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3407255" @default.
• W2053826377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22893767" @default.
• W2053826377 hasPublicationYear "2012" @default.
• W2053826377 type Work @default.
• W2053826377 sameAs 2053826377 @default.
• W2053826377 citedByCount "30" @default.
• W2053826377 countsByYear W20538263772012 @default.
• W2053826377 countsByYear W20538263772013 @default.
• W2053826377 countsByYear W20538263772014 @default.
• W2053826377 countsByYear W20538263772015 @default.
• W2053826377 countsByYear W20538263772016 @default.
• W2053826377 countsByYear W20538263772017 @default.
• W2053826377 countsByYear W20538263772018 @default.
• W2053826377 countsByYear W20538263772020 @default.
• W2053826377 countsByYear W20538263772021 @default.
• W2053826377 countsByYear W20538263772022 @default.
• W2053826377 countsByYear W20538263772023 @default.
• W2053826377 crossrefType "journal-article" @default.
• W2053826377 hasAuthorship W2053826377A5007497294 @default.
• W2053826377 hasAuthorship W2053826377A5028353205 @default.
• W2053826377 hasAuthorship W2053826377A5035079173 @default.
• W2053826377 hasAuthorship W2053826377A5049607555 @default.
• W2053826377 hasAuthorship W2053826377A5055290227 @default.
• W2053826377 hasAuthorship W2053826377A5073440750 @default.
• W2053826377 hasAuthorship W2053826377A5078140879 @default.
• W2053826377 hasBestOaLocation W20538263771 @default.
• W2053826377 hasConcept C111919701 @default.
• W2053826377 hasConcept C126322002 @default.
• W2053826377 hasConcept C164705383 @default.
• W2053826377 hasConcept C197328160 @default.
• W2053826377 hasConcept C2775841894 @default.
• W2053826377 hasConcept C2776006263 @default.
• W2053826377 hasConcept C2777935920 @default.
• W2053826377 hasConcept C2778205975 @default.
• W2053826377 hasConcept C2780168309 @default.
• W2053826377 hasConcept C2781326671 @default.
• W2053826377 hasConcept C2911073662 @default.
• W2053826377 hasConcept C41008148 @default.
• W2053826377 hasConcept C71924100 @default.
• W2053826377 hasConcept C99508421 @default.
• W2053826377 hasConceptScore W2053826377C111919701 @default.
• W2053826377 hasConceptScore W2053826377C126322002 @default.
• W2053826377 hasConceptScore W2053826377C164705383 @default.
• W2053826377 hasConceptScore W2053826377C197328160 @default.

• next